PTPA and neoplasm: We have previously identified that the specific selenium-containing compound, sodium selenate, significantly boosts the activity of the protein phosphatase PP2A, inhibits VEGF-induced growth and survival signalling in endothelial cells, and impedes tumour neovascularisation.